Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units

George Pettit; Thomas H. Smith; Jun-Ping Xu; Delbert L. Herald; Erik J. Flahive; Collin R. Anderson; Paul E. Belcher; John C. Knight

doi:10.1021/np100877h

Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units

George Pettit, Thomas H. Smith, Jun-Ping Xu, Delbert L. Herald, Erik J. Flahive, Collin R. Anderson, Paul E. Belcher, John C. Knight

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Three advances necessary to bring dolastatin 16 (1) into full-scale preclinical development as an anticancer drug have been accomplished. The X-ray crystal structure of dolastatin 16 has been solved, which allowed stereoselective syntheses of its two new amino acid units, dolamethylleuine (Dml) and dolaphenvaline (Dpv), to be completed. The X-ray crystal structures of synthetic Z-Dml and TFA-Dpv have also been completed. (Chemical Equation Presented).

Original language	English (US)
Pages (from-to)	1003-1008
Number of pages	6
Journal	Journal of Natural Products
Volume	74
Issue number	5
DOIs	https://doi.org/10.1021/np100877h
State	Published - May 27 2011

ASJC Scopus subject areas

Analytical Chemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and alternative medicine
Organic Chemistry

Access to Document

10.1021/np100877h

Fingerprint Dive into the research topics of 'Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units'. Together they form a unique fingerprint.

Cite this

Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units. / Pettit, George; Smith, Thomas H.; Xu, Jun-Ping; Herald, Delbert L.; Flahive, Erik J.; Anderson, Collin R.; Belcher, Paul E.; Knight, John C.

In: Journal of Natural Products, Vol. 74, No. 5, 27.05.2011, p. 1003-1008.

Research output: Contribution to journal › Article › peer-review

@article{eabfcc1e49a84b6ab0152dbb6a30a24f,

title = "Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units",

abstract = "Three advances necessary to bring dolastatin 16 (1) into full-scale preclinical development as an anticancer drug have been accomplished. The X-ray crystal structure of dolastatin 16 has been solved, which allowed stereoselective syntheses of its two new amino acid units, dolamethylleuine (Dml) and dolaphenvaline (Dpv), to be completed. The X-ray crystal structures of synthetic Z-Dml and TFA-Dpv have also been completed. (Chemical Equation Presented).",

author = "George Pettit and Smith, {Thomas H.} and Jun-Ping Xu and Herald, {Delbert L.} and Flahive, {Erik J.} and Anderson, {Collin R.} and Belcher, {Paul E.} and Knight, {John C.}",

year = "2011",

month = may,

day = "27",

doi = "10.1021/np100877h",

language = "English (US)",

volume = "74",

pages = "1003--1008",

journal = "Journal of Natural Products",

issn = "0163-3864",

publisher = "American Chemical Society",

number = "5",

}

TY - JOUR

T1 - Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units

AU - Pettit, George

AU - Smith, Thomas H.

AU - Xu, Jun-Ping

AU - Herald, Delbert L.

AU - Flahive, Erik J.

AU - Anderson, Collin R.

AU - Belcher, Paul E.

AU - Knight, John C.

PY - 2011/5/27

Y1 - 2011/5/27

N2 - Three advances necessary to bring dolastatin 16 (1) into full-scale preclinical development as an anticancer drug have been accomplished. The X-ray crystal structure of dolastatin 16 has been solved, which allowed stereoselective syntheses of its two new amino acid units, dolamethylleuine (Dml) and dolaphenvaline (Dpv), to be completed. The X-ray crystal structures of synthetic Z-Dml and TFA-Dpv have also been completed. (Chemical Equation Presented).

AB - Three advances necessary to bring dolastatin 16 (1) into full-scale preclinical development as an anticancer drug have been accomplished. The X-ray crystal structure of dolastatin 16 has been solved, which allowed stereoselective syntheses of its two new amino acid units, dolamethylleuine (Dml) and dolaphenvaline (Dpv), to be completed. The X-ray crystal structures of synthetic Z-Dml and TFA-Dpv have also been completed. (Chemical Equation Presented).

UR - http://www.scopus.com/inward/record.url?scp=79957862110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957862110&partnerID=8YFLogxK

U2 - 10.1021/np100877h

DO - 10.1021/np100877h

M3 - Article

C2 - 21539315

AN - SCOPUS:79957862110

VL - 74

SP - 1003

EP - 1008

JO - Journal of Natural Products

JF - Journal of Natural Products

SN - 0163-3864

IS - 5

ER -